CymitQuimica logo
Tyrosine Kinase/Adaptors

Tyrosine Kinase/Adaptors

Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.

Subcategories of "Tyrosine Kinase/Adaptors"

Show 13 more subcategories

Found 1375 products of "Tyrosine Kinase/Adaptors"

Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
products per page.
  • Margetuximab

    CAS:
    <p>Margetuximab (MGAH-22) is a second generation anti-HER2 monoclonal antibody with anti-tumor activity.</p>
    Purity:95.3% (SDS-PAGE); 99.3% (SEC-HPLC) - 95.3% (SDS-PAGE); 99.3% (SEC-HPLC)
    Color and Shape:Liquid
  • Erlotinib hydrochloride

    CAS:
    <p>Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>
    Formula:C22H23N3O4·HCl
    Purity:99.78% - 99.85%
    Color and Shape:White Or Off-White Powder
    Molecular weight:429.9
  • Bosutinib

    CAS:
    <p>Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.</p>
    Formula:C26H29Cl2N5O3
    Purity:98.98% - 99.9%
    Color and Shape:Yellowish-Orange Or Pink To Brownish Solid Solid Powder
    Molecular weight:530.45
  • AG 1295

    CAS:
    <p>AG 1295 is a selective PDGFR tyrosine-kinase inhibitor; it blocks PDGFR autophosphorylation without affecting EGF receptor.</p>
    Formula:C16H14N2
    Purity:99.64%
    Color and Shape:Solid
    Molecular weight:234.3
  • FGFR1/DDR2 inhibitor 1

    CAS:
    <p>FGFR1/DDR2 inhibitor 1 is an inhibitor of discoindin domain receptor 2 (DDR2) and fibroblast growth factor receptor 1 (FGFR1), with IC50 values of 31.1 nM, 108</p>
    Formula:C28H22F3N5O
    Purity:99.43%
    Color and Shape:Solid
    Molecular weight:501.5
  • CSF1R-IN-2

    CAS:
    <p>CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).</p>
    Formula:C20H20FN7O2
    Purity:99.29%
    Color and Shape:Solid
    Molecular weight:409.42
  • Ganitumab

    CAS:
    <p>Ganitumab (AMG 479) is a potent monoclonal antibody targeting IGF1R with 0.22 nM affinity; used in cancer research.</p>
    Purity:100% (SEC-HPLC) - > 95%
    Color and Shape:Liquid
    Molecular weight:145.70 kDa
  • Losatuxizumab

    CAS:
    <p>Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody with potential anti-tumor activity for the study of advanced malignant solid tumors.</p>
    Purity:97.3% (SDS-PAGE); 95.1% (SEC-HPLC) - 97.3% (SDS-PAGE); 95.1% (SEC-HPLC)
    Color and Shape:Liquid
  • Rilotumumab

    CAS:
    <p>Rilotumumab (AMG 102) is an HGF-targeting antibody, inhibits HGF/MET signaling, and is used for CRPC and gastric cancer research.</p>
    Purity:SDS-PAGE:95% SEC-HPLC:97.51%
    Color and Shape:Liquid
    Molecular weight:145.2 kDa
  • Emibetuzumab

    CAS:
    <p>Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.</p>
    Purity:SDS-PAGE:96.2%;SEC-HPLC:98.8%
    Color and Shape:Liquid
    Molecular weight:143.74 kDa
  • Petosemtamab

    CAS:
    <p>Petosemtamab (MCLA 158), a dual-action monoclonal antibody targets EGFR &amp; LGR5, used in solid tumor research like HNSCC &amp; CRC.</p>
    Purity:> 95% - > 95%
    Color and Shape:Liquid
    Molecular weight:145.97 kDa
  • Lanraplenib

    CAS:
    <p>Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.</p>
    Formula:C23H25N9O
    Purity:98.35%
    Color and Shape:Solid
    Molecular weight:443.5
  • Erlotinib

    CAS:
    <p>Erlotinib (NSC-718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.</p>
    Formula:C22H23N3O4
    Purity:98.19% - 99.98%
    Color and Shape:White To Off-White Powder
    Molecular weight:393.44
  • Adrenalone hydrochloride

    CAS:
    <p>Adrenalone HCl: α1-adrenoceptor agonist, topical hemostatic, vasoconstrictor, prolongs local anesthesia.</p>
    Formula:C9H11NO3·HCl
    Purity:99.94%
    Color and Shape:Solid
    Molecular weight:217.65
  • Hck-IN-1

    CAS:
    <p>Hck-IN-1 selectively inhibits Nef:Hck, IC50: 2.8 μM; &gt;20 μM for Hck alone. Potent HIV-1 Nef antagonist, IC50: 100-300 nM for HIV-1 replication.</p>
    Formula:C16H11ClN6O3S
    Purity:99.07%
    Color and Shape:Solid
    Molecular weight:402.81
  • Lapatinib Ditosylate

    CAS:
    <p>Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).</p>
    Formula:C29H26ClFN4O4S·2C7H8O3S
    Purity:99.41%
    Color and Shape:Yellow Solid
    Molecular weight:925.46
  • GSK-626616

    CAS:
    <p>GSK-626616: strong, oral DYRK3 inhibitor (IC50: 0.7 nM), affects DYRK family, may treat anemia.</p>
    Formula:C18H10Cl2N4OS
    Purity:98.27%
    Color and Shape:Solid
    Molecular weight:401.27
  • CE-245677

    CAS:
    <p>CE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases. With a cellular IC50s of 4.7 and 1 nM.</p>
    Formula:C24H22Cl2N6O3
    Purity:98.99% - 99.23%
    Color and Shape:Solid
    Molecular weight:513.38
  • F-1

    CAS:
    <p>F-1: Potent ALK/ROS1 inhibitor with 2.1-3.9 nM IC50s; suppresses p-ALK signaling.</p>
    Formula:C22H27ClN8O3S
    Purity:97.66%
    Color and Shape:Solid
    Molecular weight:519.02
  • Allitinib

    CAS:
    <p>Allitinib (AST-1306) (AST-1306) has anti-cancer activity,and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. [1]</p>
    Formula:C24H18ClFN4O2
    Purity:99.89% - 99.91%
    Color and Shape:Solid
    Molecular weight:448.88